Geron Corp (GERN)
$0.89 -5.47% Close Oct 30, 2026 Live
Geron stock today
Geron closed at $0.89 on October 30, 2026, down 5.47% on the day. Over the past year it returned -27.9% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $574 million.
$1.00$1.50$2.00
NovJan 2026MarMayJulSep
| Period | GERN | S&P 500 (SPY) |
|---|---|---|
| 1 month | -27.3% | -0.9% |
| 3 months | -33.3% | +2.1% |
| Year to date | -32.2% | +11.7% |
| 1 year | -27.9% | +12.4% |
| 3 years | -53.2% | +88.5% |
| 5 years | -41.9% | +76.0% |
Key statistics
- Market value
- $574M
- Price / sales
- 2.8
- 52-week range
- $0.89 to $1.95
- Next report
- Nov 4, 2026
About Geron
Geron Corp develops telomerase-based cancer immunotherapies.
Sector: Health Care
More on Geron
- Financials: revenue, earnings and segmentsRevenue +139% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $456.33 today
No forecast, no recommendation. This page describes Geron Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.